In response to overwhelming concerns from our community The Brain Tumour Charity met with the Driver and Vehicle Licensing Agency (DVLA) in Swansea to discuss issues around driving and brain tumours.

A team at The Scripps Research Institute, USA, have been able to identify a cellular pathway used by glioblastoma (GBM) tumours to allow them to survive, that could be exploited therapeutically to halt tumour growth.

Grace, 23, recently filmed her first video blog for us where she asked our community for any questions about diagnosis, symptoms and effects and life after surgery. Her honest and heartfelt answers are now documented in a video diary.

A report today from Cancer Research UK predicts that survival from brain tumours will remain virtually unchanged over the next 20 years, despite an expected fall of 15% overall in the number of cancer deaths by 2035.

Dr Paul Brennan, from the University of Edinburgh, shares a round-up of his research with us.

The Biobanking Consensus Meeting, initiated by us, is being held at Islington’s Business Design Centre in London.

Researchers from Toronto and Montreal have successfully identified three distinct sub-groups of classification of the incurable typical teratoid rhabdoid tumours (ATRTs).

A drug that can extend the lives of brain tumour patients is being withheld by some NHS Trusts on the grounds of cost.

In order to ensure that we fund only the highest quality research, we have formed two Scientific Advisory Boards (SABs) which are made up of internationally renowned scientific and medical experts that work in different areas of cancer research and social science.

Beccy Shortt, our Senior Policy and Public Affairs Manager at The Brain Tumour Charity explores the barriers surrounding brain tumour research.

Researchers at the University of Texas Southwestern Medical Center in Dallas have identified a gene called SHOX2 that could be used to better diagnose brain tumours.

“We will always do things differently if it’s the right thing for people affected by a brain tumour. That’s why we’re investing in The Brain Tumour Fund.” – Sarah Lindsell, CEO of The Brain Tumour Charity

Julien Baptiste’s character, played by acclaimed actor Tchéky Karyo, steered the second series of the award-winning drama with the diagnosis of a brain tumour framing his actions and decisions as a key aspect of the storyline.

Lewis Moody MBE, co-Founder of The Foundation and headeast organiser, polar explorer Alan Chambers MBE and 10 other fearless cycling challengers have saddled up in Saigon.

Research carried out at the University of Edinburgh has revealed a new alliance between immune cells and glioblastoma tumour cells in zebrafish.

Patients diagnosed with cancer should be told clearly how the NHS will store and use information about their case to help others in future, says a new report.

Our Director of Services and Influencing, Emma Tingley, shares her thoughts on navigating the system after a brain tumour diagnosis, and our recently launched Patient Guide.

A battery-powered cap that disrupts the growth of brain tumour cells could help glioblastoma patients to survive for longer, new findings suggest.

The Paediatric Brain Tumor Atlas Project has been launched by Cancer MoonShot 2020.

The Science and Technology Select Committee has today published a new report on the implications and opportunities of leaving the EU for science and research in the UK.

We caught up with Dr Paul Brennan from the University of Edinburgh to hear more about his research.

The new Seimens Magnetom Terra 7 Tesla MRI machine is being installed in Glasgow in March 2017.

Professor Richard Gilbertson, tells us about his move to The Cambridge Cancer Centre and his plans for the future or brain tumour research

Our Patient Guide launches today to help people living with a brain tumour better navigate the healthcare system.